Stem cell marker CD133 affects clinical outcome in glioma patients.
Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC.
Zeppernick F, et al. Among authors: helmke bm.
Clin Cancer Res. 2008 Jan 1;14(1):123-9. doi: 10.1158/1078-0432.CCR-07-0932.
Clin Cancer Res. 2008.
PMID: 18172261